Successful conversion surgery following tislelizumab with chemotherapy in a patient with stage IIIC...
Successful conversion surgery following tislelizumab with chemotherapy in a patient with stage IIIC lung adenocarcinoma harboring RET fusions: A case report and review of the literature
About this item
Full title
Author / Creator
Tu, De-Hao , Qu, Rirong , Wen, Fang , Zhou, Qiang , Liu, Qianyun , Huang, Lingmei and Chen, Tao
Publisher
D.A. Spandidos
Journal title
Language
English
Formats
Publication information
Publisher
D.A. Spandidos
Subjects
More information
Scope and Contents
Contents
Immune checkpoint inhibitors (ICIs) have emerged as a beacon of hope for most patients with stage III non-small cell lung cancer (NSCLC) who are no longer surgical candidates. However, the literature on the use of immunotherapy in patients with NSCLC with rearranged during transfection (RET) gene fusions is scant. The present study reports the case...
Alternative Titles
Full title
Successful conversion surgery following tislelizumab with chemotherapy in a patient with stage IIIC lung adenocarcinoma harboring RET fusions: A case report and review of the literature
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11843209
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11843209
Other Identifiers
ISSN
1792-0981
E-ISSN
1792-1015
DOI
10.3892/etm.2025.12820
